Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Exposure during pregnancy, Pregnancy test, Prenatal screening test, Ultrasound abdomen
Clinical narrative: pregnant; This spontaneous retrospective pregnancy case was reported by an other health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Pregnant (Live, full-term birth) and Alcohol use (Variable 1-5 drinks a week) from 2010 to 02-Jun-2020. Concurrent medical conditions included Mental disorder, Obsessive-compulsive disorder (Meds Increased during pregnancyy) since 2000, ADHD (Unmedicated - no change during pregnancy) since 1998, Bipolar disorder (Meds increased during pregnancy) since 2007, Asthma (no changes) since 1997, Irritable bowel syndrome (Symptoms improved during pregnancy) since 2021 and Gestational diabetes (started on insulin). Concomitant products included GLICLAZIDE (CLARITIN [GLICLAZIDE]) for Allergy, LAMOTRIGINE from 2007 to an unknown date for Bipolar disorder, HYDROXYZINE from an unknown date to 05-Feb-2021 for Insomnia, FLUVOXAMINE from 2000 to an unknown date for Obsessive-compulsive disorder, PROPRANOLOL (PROPANOLOL [PROPRANOLOL]) from 2019 to 05-Feb-2021 for Restless leg syndrome, INSULIN from 11-Jan-2021 to 05-Feb-2021 for an unknown indication.    On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 02-May-2020 and the estimated date of delivery was 10-Feb-2021. On 26-Dec-2020, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fourth week of the pregnancy. The vaginal delivery occurred Feb-2021, which was reported as Full-term. For neonate 1, the birth weight was 3500 grams (7lbs 11oz) with an APGAR score of 2 and 8 at (1, 5 minutes). The outcome was reported as Term Birth NOS. Nuchal Cord Discovered during delivery. On 26-Dec-2020, EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jun-2020, Pregnancy test: Positive. On 15-Jul-2020, Prenatal screening test: normal (normal) No Genetic Problems detected , Female Fetus. On 04-Aug-2020, Ultrasound abdomen: normal (normal) Single Fetus, Normal Anatomy. On 24-Nov-2020, Blood glucose: 148 (High) above cut off 148mg/dl. On an unknown date, Blood glucose: abnormal (abnormal) Diagnosed with gestational diabetes.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medicines were reported   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: updated patient demographics, added Medical history, Delivery information, Lab data, updated Concomitant medications, added new concomitant medicines; Reporter's Comments: This case concerns a 35-year-old female patient with medical history of mental ilines who reported pregnancy during the first dose of Moderna vaccine mRNA-1273. lamotrigine, fluvoxamine, gliclazide, propranolol and hydroxyzine. Estimated due date is 21-Oct-2021. No AE was reported at the time of this reported and company causality was assessed as not applicable.